Identification and Validation of Poor Prognosis Immunoevasive Subtype of Muscle-Invasive Bladder Cancer With Tumor-Infiltrating Podoplanin+ Cell Abundance

OncoImmunology - United States
doi 10.1080/2162402x.2020.1747333
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Circulating and Tumor-Infiltrating Myeloid Cell Subsets in Patients With Bladder Cancer

International Journal of Cancer
Cancer ResearchOncology
2011English

The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients With Non-Muscle Invasive Bladder Cancer.

Clinical Cancer Research
Cancer ResearchOncology
2018English

Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

An Independent Poor-Prognosis Subtype of Breast Cancer Defined by a Distinct Tumor Immune Microenvironment

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Contemporary Management of Muscle-Invasive Bladder Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2012English

Long Non-Coding RNAs Identify a Subset of Luminal Muscle-Invasive Bladder Cancer Patients With Favorable Prognosis

Genome Medicine
Molecular MedicineGeneticsMolecular Biology
2019English

Mutational Landscape of Non-Muscle-Invasive Bladder Cancer

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2018English

Overexpression of Thymosin Β10 Correlates With Disease Progression and Poor Prognosis in Bladder Cancer

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Identification of miR-200c and miR141-Mediated lncRNA-mRNA Crosstalks in Muscle-Invasive Bladder Cancer Subtypes

Frontiers in Genetics
GeneticsMolecular Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy